Generation Bio raises $100M for ‘druglike’ gene therapy – FierceBiotech
FierceBiotech |
Generation Bio raises $100M for 'druglike' gene therapy
FierceBiotech Gene therapy startup Generation Bio has lost no time raising the resources it needs to take its programs forward into the clinic, closing a $100 million second-round financing just over a month after its $25 million Series A. The Atlas Venture-backed … Fresh Off $25M Raise, Generation Adds $100M For Next-Gen Gene Therapy Hauling in a $100M mega-round, gene therapy startup Generation Bio builds alternative to potentially risky viral vectors Redosable Gene–Therapy Developer Generation Bio Wins $100M Series B Financing |
